GenRx Entecavir entecavir (as monohydrate) 1mg tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

entecavir, Quantity: 1 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

Entecavir

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: lactose monohydrate; hyprolose; crospovidone; magnesium stearate; titanium dioxide; iron oxide red; microcrystalline cellulose; macrogol 8000; copovidone; hypromellose

Mode d'administration:

Oral

Unités en paquet:

30

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults 16 years or older with evidence of active liver inflammation.,This indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease.

Descriptif du produit:

Visual Identification: Pink colored, triangular shaped film coated tablets, engraved 'APO' on one side and '1' over 'ENT' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2016-03-10